[144] ESTEE LAUDER COMPANIES INC SEC Filing

Rhea-AI Filing Summary

A shareholder of Estée Lauder (EL) has filed a Form 144 notice to potentially sell 5,430 shares of the company’s common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/18/2025. The shares have an stated aggregate market value of $476,992.92, compared with 234,818,211 common shares outstanding. The securities to be sold were acquired as restricted stock directly from the issuer on multiple dates between 05/17/2022 and 11/03/2025, indicating these are previously granted equity awards now eligible for resale under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5430	476992.92	234818211	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/03/2025	Restricted Stock	Issuer			2235	11/03/2025	Not Applicable
Common	11/01/2023	Restricted Stock	Issuer			499	11/01/2023	Not Applicable
Common	05/17/2022	Restricted Stock	Issuer			502	05/17/2022	Not Applicable
Common	05/17/2023	Restricted Stock	Issuer			503	05/17/2023	Not Applicable
Common	05/17/2024	Restricted Stock	Issuer			503	05/17/2024	Not Applicable
Common	11/01/2022	Restricted Stock	Issuer			141	11/01/2022	Not Applicable
Common	11/01/2024	Restricted Stock	Issuer			1047	11/01/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Estée Lauder (EL) shares are proposed to be sold in this Form 144?

The notice covers a proposed sale of 5,430 shares of Estée Lauder common stock.

What is the aggregate market value of the Estée Lauder (EL) shares in this Form 144?

The aggregate market value of the shares covered by the notice is stated as $476,992.92.

How many Estée Lauder (EL) shares are outstanding compared with this Form 144 sale?

The filing reports 234,818,211 Estée Lauder common shares outstanding, providing context for the 5,430 shares covered by this notice.

When is the approximate sale date for the Estée Lauder (EL) shares under this Form 144?

The approximate date of sale listed is 11/18/2025.

Through which broker and exchange will the Estée Lauder (EL) shares be sold?

The proposed sale is through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.

How were the Estée Lauder (EL) shares in this Form 144 acquired?

The shares were acquired as restricted stock from the issuer on several dates, including 05/17/2022, 05/17/2023, 05/17/2024, 11/01/2022, 11/01/2023, 11/01/2024, and 11/03/2025.